List view / Grid view

Webinars

Overcoming critical challenges in AI-driven drug discovery

25 November 2024 By Drug Target Review

The increasing use of AI in the life science field marks a pivotal point in history. Although AI is now an indispensable tool in drug discovery, promising to save vast amounts of time and money, there are still many hurdles scientists encounter. This webinar will explore these challenges and offer…

HIV vaccine development: current challenges and emerging solutions

28 October 2024 By Drug Target Review

In recent years, HIV research has made significant strides, bringing us closer to new preventative and therapeutic solutions. Join us for this webinar to gain insights into the latest advancements in HIV vaccine development, including challenges, breakthroughs and future directions in the field.

The value of GPCR cell-based assays in drug discovery

ON-DEMAND By Eurofins DiscoverX

Join this webinar to discover how GPCR functional, cell-based assays determine off-target effects, reveal safety issues, and define drug mechanism of action to ultimately evaluate the therapeutic potential of candidate molecules.

Immunotherapy advancements: transforming cancer treatment

ON-DEMAND By Drug Target Review

In recent years, immunotherapy has emerged as a revolutionary approach in cancer treatment, harnessing the power of the immune system to combat cancer cells. This webinar will explore the latest advancements in immunotherapy research, highlighting breakthroughs, challenges, and future directions in the field. Participants will gain insights, including immune checkpoint…

Neurological disorders: organoids for early drug discovery

ON-DEMAND By Drug Target Review

Join us for this webinar as we explore the role of organoids in advancing treatment of neurological disorders. Organoids, miniature 3D models of human organs, are at the forefront of neuroscience research, offering insights into the complexities of the human brain. In this webinar, esteemed experts will explore the latest…

SAFIRE: AI predicted ADME for drug discovery: leveraging BioPrint

ON-DEMAND By Eurofins Discovery

Join Dr Carleton Sage to learn about predicting ADME properties as a key approach to improving the efficiency of small molecule drug discovery. AI ADME model development approaches and case studies within drug discovery projects will be discussed.

Developing next generation non-replicative HSV-1 vectors for sustainable and more precise gene therapies

ON-DEMAND By Drug Target Review, sponsored by Bio Rad Technologies

Watch this webinar to learn how the challenges with using certain viral vectors in gene therapy has advanced the development of a new generation of precise vectors with sustainable effects. Our experts outline the limitations of existing vectors and how these can be overcome using modified recombinant non-replicative herpes simplex…